Description:VGX-1027, with the CAS number 6501-72-0, is a synthetic peptide that has been investigated primarily for its potential therapeutic applications, particularly in the context of autoimmune diseases and inflammation. It is a derivative of the immunomodulatory peptide sequence and is designed to modulate immune responses. VGX-1027 is characterized by its ability to enhance the activity of regulatory T cells while suppressing pro-inflammatory cytokines, which may help in restoring immune balance. The substance is typically administered via injection and has been studied in various preclinical and clinical settings. Its safety profile and efficacy are subjects of ongoing research, with a focus on its potential to treat conditions such as multiple sclerosis and other inflammatory disorders. As with many investigational compounds, the specific pharmacokinetics, mechanism of action, and long-term effects are still being elucidated through clinical trials.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
